Canada Life’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74K | Buy |
5,705
+241
| +4% | +$3.13K | ﹤0.01% | 1793 |
|
|
2025
Q1 | $58K | Sell |
5,464
-15
| -0.3% | -$159 | ﹤0.01% | 1846 |
|
|
2024
Q4 | $92K | Sell |
5,479
-571
| -9% | -$9.59K | ﹤0.01% | 1825 |
|
|
2024
Q3 | $140K | Buy |
6,050
+701
| +13% | +$16.2K | ﹤0.01% | 1813 |
|
|
2024
Q2 | $130K | Buy |
5,349
+857
| +19% | +$20.8K | ﹤0.01% | 1850 |
|
|
2024
Q1 | $152K | Buy |
4,492
+428
| +11% | +$14.5K | ﹤0.01% | 1868 |
|
|
2023
Q4 | $127K | Sell |
4,064
-341
| -8% | -$10.7K | ﹤0.01% | 1899 |
|
|
2023
Q3 | $112K | Buy |
4,405
+1,825
| +71% | +$46.4K | ﹤0.01% | 1940 |
|
|
2023
Q2 | $74K | Sell |
2,580
-99
| -4% | -$2.84K | ﹤0.01% | 1957 |
|
|
2023
Q1 | $64K | Buy |
2,679
+616
| +30% | +$14.7K | ﹤0.01% | 2030 |
|
|
2022
Q4 | $35K | Buy |
2,063
+247
| +14% | +$4.19K | ﹤0.01% | 2146 |
|
|
2022
Q3 | $27K | Buy |
1,816
+167
| +10% | +$2.48K | ﹤0.01% | 2204 |
|
|
2022
Q2 | $26K | Buy |
1,649
+186
| +13% | +$2.93K | ﹤0.01% | 2208 |
|
|
2022
Q1 | $41K | Buy |
1,463
+150
| +11% | +$4.2K | ﹤0.01% | 2200 |
|
|
2021
Q4 | $48K | Buy |
1,313
+145
| +12% | +$5.3K | ﹤0.01% | 2181 |
|
|
2021
Q3 | $56K | Hold |
1,168
| – | – | ﹤0.01% | 2200 |
|
|
2021
Q2 | $39K | Hold |
1,168
| – | – | ﹤0.01% | 2333 |
|
|
2021
Q1 | $48K | Hold |
1,168
| – | – | ﹤0.01% | 2306 |
|
|
2020
Q4 | $51K | Hold |
1,168
| – | – | ﹤0.01% | 2269 |
|
|
2020
Q3 | $50K | Hold |
1,168
| – | – | ﹤0.01% | 2178 |
|
|
2020
Q2 | $54K | Buy |
+1,168
| New | +$54K | ﹤0.01% | 2203 |
|